CN107385091B - Cdc42bpa作为结直肠癌转移诊断与预测预后的生物标志物 - Google Patents
Cdc42bpa作为结直肠癌转移诊断与预测预后的生物标志物 Download PDFInfo
- Publication number
- CN107385091B CN107385091B CN201710801809.8A CN201710801809A CN107385091B CN 107385091 B CN107385091 B CN 107385091B CN 201710801809 A CN201710801809 A CN 201710801809A CN 107385091 B CN107385091 B CN 107385091B
- Authority
- CN
- China
- Prior art keywords
- cdc42bpa
- colorectal cancer
- protein
- metastasis
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710801809.8A CN107385091B (zh) | 2017-09-07 | 2017-09-07 | Cdc42bpa作为结直肠癌转移诊断与预测预后的生物标志物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710801809.8A CN107385091B (zh) | 2017-09-07 | 2017-09-07 | Cdc42bpa作为结直肠癌转移诊断与预测预后的生物标志物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107385091A CN107385091A (zh) | 2017-11-24 |
CN107385091B true CN107385091B (zh) | 2021-02-12 |
Family
ID=60351475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710801809.8A Active CN107385091B (zh) | 2017-09-07 | 2017-09-07 | Cdc42bpa作为结直肠癌转移诊断与预测预后的生物标志物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107385091B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113710800A (zh) * | 2019-04-18 | 2021-11-26 | 学校法人庆应义塾 | 检测结直肠癌的致癌风险的方法和试剂盒 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160068912A1 (en) * | 2014-09-09 | 2016-03-10 | Kuwait University | Method for determining risk of metastatic relapse in a patient diagnosed with colorectal cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070087985A1 (en) * | 2005-04-19 | 2007-04-19 | Gundersen Gregg G | MRCK-related compositions and methods |
-
2017
- 2017-09-07 CN CN201710801809.8A patent/CN107385091B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160068912A1 (en) * | 2014-09-09 | 2016-03-10 | Kuwait University | Method for determining risk of metastatic relapse in a patient diagnosed with colorectal cancer |
Non-Patent Citations (1)
Title |
---|
supplmentary materials: identification of 42 genes linked to stage II colorectal cancer metastatic relapse;al-temaimi ra等;《Int j mol sci》;20161231;第17卷;第598篇,S1-S16 * |
Also Published As
Publication number | Publication date |
---|---|
CN107385091A (zh) | 2017-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10131955B2 (en) | Methods for detecting genetic and phenotypic biomarkers of urothelial carcinoma and treatment thereof | |
US11208698B2 (en) | Methods for detection of markers bladder cancer and inflammatory conditions of the bladder and treatment thereof | |
Das et al. | Cross validation of the monoclonal antibody Das-1 in identification of high-risk mucinous pancreatic cystic lesions | |
CN101652484B (zh) | 前列腺癌标志物spink1及其应用 | |
Kadara et al. | A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis | |
CN102459646B (zh) | 胃癌的检测标志物 | |
CN103293307B (zh) | Satb2蛋白作为结肠直肠癌标记的应用 | |
WO2008058018A2 (en) | Predicting cancer outcome | |
US20170146541A1 (en) | Detection of high-risk intraductal papillary mucinous neoplasm and pancreatic adenocarcinoma | |
US20210231669A1 (en) | Method for diagnosing pancreatic cancer using methionyl-trna synthetase, and pancreatic cancer diagnostic kit using same | |
CN107385091B (zh) | Cdc42bpa作为结直肠癌转移诊断与预测预后的生物标志物 | |
US20120040361A1 (en) | Methods and compositions for detection of lethal system and uses thereof | |
CN112795658A (zh) | 早期结直肠癌的基于生物标志物的诊断 | |
EP2850209A1 (en) | Methods to predict progression of barrett ' s esophagus to high grade dysplasia esophageal adenocarcinoma | |
KR20240054172A (ko) | 엑소좀 유래의 대장암 진단용 바이오 마커 및 이의 용도 | |
EP4413366A2 (en) | Tibtech methods and compositions for detecting cdh17 | |
CN112921094A (zh) | 生物标志物用于评估早期结直肠癌 | |
CN113025717A (zh) | 早期结直肠癌的指示物 | |
CN112921095A (zh) | 用于诊断早期结直肠癌的生物标志物及其应用 | |
CN112921096A (zh) | 早期结直肠癌的预测 | |
CN113061657A (zh) | 诊断早期结直肠癌的产品及系统 | |
WO2015114350A1 (en) | Biomarker | |
Zhang et al. | Multiplex Immunohistochemistry Indicates Biomarkers in Colorectal Cancer Authors and affiliations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 510632 No. 601, Whampoa Avenue, Tianhe District, Guangdong, Guangzhou Patentee after: Jinan University Patentee after: Zhuhai Tainuo Maibo Pharmaceutical Co.,Ltd. Patentee after: GUANGZHOU TAINUODI BIOTECHNOLOGY Co.,Ltd. Address before: 510632 No. 601, Whampoa Avenue, Tianhe District, Guangdong, Guangzhou Patentee before: Jinan University Patentee before: ZHUHAI TRINOMAB BIOTECHNOLOGY Co.,Ltd. Patentee before: GUANGZHOU TAINUODI BIOTECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230816 Address after: 510632 No. 601, Whampoa Avenue, Tianhe District, Guangdong, Guangzhou Patentee after: Jinan University Patentee after: Zhuhai Tainuo Maibo Pharmaceutical Co.,Ltd. Address before: 510632 No. 601, Whampoa Avenue, Tianhe District, Guangdong, Guangzhou Patentee before: Jinan University Patentee before: Zhuhai Tainuo Maibo Pharmaceutical Co.,Ltd. Patentee before: GUANGZHOU TAINUODI BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |